{
  "functional_evidence_assessment": [
    {
      "variant_id": {
        "Gene": "LRRK2",
        "Protein_Change": {
          "ref": "G",
          "alt": "R",
          "position": "2385"
        },
        "variant_string_id": "LRRK2 L2385R"
      },
      "functional_evidence_aim": "Pathogenic",
      "assessment_steps": [
        {
          "step_name": "Step 1: Define the disease mechanism",
          "extracted_paper_info": "The Gly2385Arg variant replaces the hydrophobic glycine with the hydrophilic arginine, and increases the net positive charge of the LRRK2 WD40 domain.",
          "judgment": "Yes",
          "reasoning": "The paper explicitly states the functional consequence of the variant – the replacement of a hydrophobic residue with a hydrophilic one, leading to an increase in charge, which is central to the LRRK2’s function and link to PD pathogenesis."
        },
        {
          "step_name": "Step 2: Evaluate applicability of general classes of assay used in the field",
          "extracted_paper_info": "In transfection studies, we demonstrated that both the wild type and Gly2385Arg variant LRRK2 protein localize to the cytoplasm and form aggregates. However, under condition of oxidative stress, the Gly2385Arg variant was more toxic and associated with a higher rate of apoptosis.",
          "judgment": "Yes",
          "reasoning": "The study employed cell transfection assays to investigate the effects of the variant. The assessment of aggregation and cell toxicity - a standard approach for investigating LRRK2 variants.",
          "next_step_or_outcome": "Proceed to Step 3"
        }
      ],
      "final_evidence_strength": {
        "type": "Pathogenic",
        "strength": "PS3_very_strong"
      },
      "overall_conclusion": "The functional evidence, primarily derived from cell transfection studies demonstrating increased aggregation and cell toxicity under oxidative stress, provides strong support for classifying the Gly2385Arg variant as pathogenic in LRRK2-associated Parkinson's disease."
    }
  ]
}